Non Invasive Prenatal Testing Market: Information by Product (Consumables, Instruments), Method, Application, End User and Regional Outlook — Forecast Till 2026

Mar 31, 2019   Global Statistics Representing Non-Invasive Prenatal Testing Market Scenario Non-invasive prenatal testing is a procedure to determine the genetic abnormalities of the fetus. The procedure is used to screen fetus for genetic disorders such as, Down syndrome, Edwards syndrome and Patausyndrome. The test is basically recommended to elder women at high risk for carrying baby with genetic abnormalities. Increasing age maternal age around the world and rising number of working women in developing r...
Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Non-Invasive Prenatal TestingMarket

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          Product Overview

4.1       Introduction

4.1.1    Market Size & Forecast

4.2       Consumables

4.2.1    Market Size & Forecast

4.2.2    Assay Kits & Reagents

4.2.3    Disposables

4.3       Instruments

4.3.1    Market Size & Forecast

4.3.2    Ultrasound Devices

4.3.3    Next-Generation Sequencing Systems

4.3.4    Polymerase Chain Reaction Instruments

4.3.5    Microarrays

4.3.6    Other Instruments     

5          Method Overview

5.1       Introduction

5.1.1    Market Size & Forecast

5.2       Ultrasound Detection

5.2.1    Market Size & Forecast

5.3       Biochemical Screening Tests

5.3.1    Market Size & Forecast

5.4       Cell-Free DNA in Maternal Plasma Tests

5.4.1    Market Size & Forecast

5.5       Fetal Cells in Maternal Blood Tests

5.5.1    Market Size & Forecast

6          ApplicationOverview

6.1       Introduction

6.1.1    Market Size & Forecast

6.2       Trisomy

6.2.1    Market Size & Forecast

6.3       Microdeletion Syndrome

6.3.1    Market Size & Forecast

6.4       Other Applications

6.4.1    Market Size & Forecast

7          End User Overview

7.1       Introduction

7.1.1    Market Size & Forecast

7.2       Diagnostic Laboratories

7.2.1    Market Size & Forecast

7.3       Hospitals

7.3.1    Market Size & Forecast

8          Regional Overview

8.1       Introduction

8.1.1    Market Size & Forecast

8.2       America

8.2.1    North America

8.2.1.1 U.S.

8.2.1.1.1          By Product

8.2.1.1.2          By Method

8.2.1.1.3          By Application

8.2.1.1.4          By End User

8.2.1.2 Canada

8.2.1.2.1          By Product

8.2.1.2.2          By Method

8.2.1.2.3          By Application

8.2.1.2.4          By End User

8.2.1.3 Mexico

8.2.1.3.1          By Product

8.2.1.3.2          By Method

8.2.1.3.3          By Application

8.2.1.3.4          By End User

8.2.2    Latin America

8.2.2.1             By Product

8.2.2.2             By Method

8.2.2.3             By Application

8.2.2.4             By End User

8.3       Europe

8.3.1    Market Size & Forecast

8.3.2    Germany

8.3.2.1 By Product

8.3.2.2 By Method

8.3.2.3 By Application

8.3.2.4 By End User

8.3.3    France

8.3.3.1 By Product

8.3.3.2 By Method

8.2.3.3 By Application

8.3.3.4 By End User

8.3.4    U.K.

8.3.4.1 By Product

8.3.4.2 By Method

8.3.4.3 By Application

8.3.4.4 By End User

8.3.5    Italy

8.3.5.1 By Product

8.3.5.2 By Method

8.3.5.3 By Application

8.3.5.4 By End User

8.3.6    Spain

8.3.6.1 By Product

8.3.6.2 By Method

8.3.6.3 By Application

8.3.6.4 By End User

8.3.7    Rest of Europe

8.3.7.1 By Product

8.3.7.2 By Method

8.3.7.3 By Application

8.3.7.4 By End User

 

8.4       AsiaPacific

8.4.1    Market Size & Forecast

8.4.2    Japan

8.4.2.1 By Product

8.4.2.2 By Method

8.4.2.3 By Application

8.4.2.4 By End User

8.4.3    China

8.4.3.1 By Product

8.4.3.2 By Method

8.4.3.3 By Application

8.4.3.4 By End User

8.4.4    Australia

8.4.4.1 By Product

8.4.4.2 By Method

8.4.4.3 By Application

8.4.4.4 By End User

8.4.5    India

8.4.5.1 By Product

8.4.5.2 By Method

8.4.5.3 By Application

8.4.5.4 By End User

8.4.6    South Korea

8.4.6.1 By Product

8.4.6.2 By Method

8.4.6.3 By Application

8.4.6.4 By End User

8.4.7    Rest of Asia-Pacific

8.4.7.1 By Product

8.4.7.2 By Method

8.4.7.3 By Application

8.4.7.4 By End User

8.5       Middle East & Africa

8.5.1    Market Size & Forecast

8.5.2    Saudi Arabia

8.5.2.1 By Product

8.5.2.2 By Method

8.5.2.3 By Application

8.5.2.4 By End User

8.5.3    South Africa

8.5.3.1 By Product

8.5.3.2 By Method

8.5.3.3 By Application

8.5.3.4 By End User

8.5.4    Brazil

8.5.4.1 By Product

8.5.4.2 By Method

8.5.4.3 By Application

8.5.4.4 By End User

8.5.5    Rest of Middle East & Africa

8.5.5.1 By Product

8.5.5.2 By Method

8.5.5.3 By Application

8.5.5.4 By End User

9          Company Profile

9.1       Thermo Fisher Scientific

9.1.1    Company Overview

9.1.2    Financial Performance

9.1.3    Recent Developments

9.1.4    Product Portfolio

9.2       Illumina, Inc.

9.2.1    Company Overview

9.2.2    Financial Performance

9.2.3    Recent Developments

9.2.4    Product Portfolio

9.3       F. Hoffmann-La Roche Ltd

9.3.1    Company Overview

9.3.2    Financial Performance

9.3.3    Recent Developments

9.3.4    Product Portfolio

9.4       QIAGEN N.V.

9.4.1    Company Overview

9.4.2    Financial Performance

9.4.3    Recent Developments

9.4.4    Product Portfolio

9.5       PerkinElmer, Inc.

9.5.1    Company Overview

9.5.2    Financial Performance

9.5.3    Recent Developments

9.5.4    Product Portfolio

9.6       Agilent Technologies, Inc.

9.6.1    Company Overview

9.6.2    Financial Performance

9.6.3    Recent Developments

9.6.4    Product Portfolio

9.7       Beijing Genomics Institute

9.7.1    Company Overview

9.7.2    Financial Performance

9.7.3    Recent Developments

9.7.4    Product Portfolio

9.8       Koninklijke Philips N.V.

9.8.1    Company Overview

9.8.2    Financial Performance

9.8.3    Recent Developments

9.8.4    Product Portfolio

9.9       Pacific Biosciences of California

9.9.1    Company Overview

9.9.2    Financial Performance

9.9.3    Recent Developments

9.9.4    Product Portfolio

9.10     GE Healthcare

9.10.1  Company Overview

9.10.2  Financial Performance

9.10.3  Recent Developments

9.10.4  Product Portfolio

Copyright . All rights Reserved By Straits Research